Literature DB >> 22372916

Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).

Md Akhlaquer Rahman1, Arshad Hussain, Md Sarfaraj Hussain, Mohd Aamir Mirza, Zeenat Iqbal.   

Abstract

The oral delivery of hydrophobic drug presents a major challenge because of the low aqueous solubility of such compounds. Self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS), which are isotropic mixtures of oils, surfactants, solvents and co-solvents/surfactants, can be used for the design of formulations in order to improve the oral absorption of highly lipophilic drug compounds. The efficiency of oral absorption of said drug from such type of formulation depends on many formulation-related parameters, such as surfactant concentration, oil/surfactant ratio, polarity of the emulsion, droplet size and charge, all of which in essence determine the self-emulsification ability. Thus, only very specific pharmaceutical excipient combinations will lead to efficient self-emulsifying systems. With the growing interest in this field, there is an increasing need for guidelines in excipient selection to obtain effective delivery system with improved bioavailability. The aim of this review is to present the recent approaches in selecting the most appropriate lipid system(s); methods for its characterization and role of various excipients for improved delivery of dosage form.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372916     DOI: 10.3109/03639045.2012.660949

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  15 in total

1.  Evidences for anti-mycobacterium activities of lipids and surfactants.

Authors:  Afzal Hussain; Sandeep Kumar Singh
Journal:  World J Microbiol Biotechnol       Date:  2015-12-28       Impact factor: 3.312

Review 2.  Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems.

Authors:  Heejun Park; Eun-Sol Ha; Min-Soo Kim
Journal:  Pharmaceutics       Date:  2020-04-16       Impact factor: 6.321

Review 3.  Self-Emulsifying Systems for Delivery of Bioactive Compounds from Natural Origin.

Authors:  Mariana Carla de Oliveira; Marcos Luciano Bruschi
Journal:  AAPS PharmSciTech       Date:  2022-05-09       Impact factor: 3.246

Review 4.  Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems.

Authors:  Daniélle van Staden; Richard K Haynes; Joe M Viljoen
Journal:  Antibiotics (Basel)       Date:  2022-06-15

5.  Formulation and statistical optimization of self-microemulsifying drug delivery system of eprosartan mesylate for improvement of oral bioavailability.

Authors:  Pankaj Dangre; Ritu Gilhotra; Shashikant Dhole
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 6.  Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.

Authors:  Conglian Yang; Tingting Wu; Yan Qi; Zhiping Zhang
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

Review 7.  Advances in drug delivery systems: Work in progress still needed?

Authors:  Flavia Laffleur; Valérie Keckeis
Journal:  Int J Pharm X       Date:  2020-06-12

8.  Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation.

Authors:  Yu Ma; Jingjing Yang; Yali Zhang; Chunyan Zheng; Zhen Liang; Ping Lu; Fei Song; Yuwei Wang; Junjie Zhang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 9.  Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.

Authors:  Sivacharan Kollipara; Rajesh Kumar Gandhi
Journal:  Acta Pharm Sin B       Date:  2014-10-08       Impact factor: 11.413

10.  A Mixed Micellar Formulation for the Transdermal Delivery of an Indirubin Analog.

Authors:  Seol Hwa Seo; Eunhwan Kim; Yechan Joo; Juseung Lee; Kyung Taek Oh; Sung-Joo Hwang; Kang-Yell Choi
Journal:  Pharmaceutics       Date:  2020-02-19       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.